Role of phospholamban in No/EDRF-induced relaxation in rat aorta

This publication has 24 references indexed in Scilit:

• Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide
  Nature, 1990
• Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
  Circulation Research, 1989
• Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells
  Biochemical and Biophysical Research Communications, 1988
• Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
  Circulation Research, 1987
• 8‐Bromoguanosine 3′:5′‐cyclic monophosphate decreases intracellular free calcium concentrations in cultured vascular smooth muscle cells from rat aorta
  FEBS Letters, 1987
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
  Nature, 1987
• Atriopeptin II decreases cytosolic free Ca in cultured vascular smooth muscle cells
  American Journal of Physiology-Cell Physiology, 1986
• Myosin phosphorylation and cyclic adenosine 3',5'-monophosphate in relaxation of arterial smooth muscle by vasodilators.
  Circulation Research, 1984
• Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation
  Nature, 1983
• Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP.
  Circulation Research, 1983